Steve Curd

President and CEO, Scaeva Technologies

Steve Curd, a healthtech and biotech C-suite executive with accolades for defining successful business models and delivering new products to market, participated in raising over $800 million in career capital, 15 M&A transactions and four exits / IPO. His expertise includes advanced clinical imaging solutions, mobile technologies, precision/personalized medicine, genomics platforms, payer and population health platforms, remote patient monitoring via IoT devices and FDA 510k / QMS experience.

This document was retrieved from on Sat, 23 Feb 2019 00:22:38 -0500.